- Home
- PPSI vs MRSN Comparison
PPSI vs MRSN Comparison
Compare PPSI & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- MRSN
- Stock Information
- Founded
- PPSI 2008
- MRSN 2001
- Country
- PPSI United States
- MRSN United States
- Employees
- PPSI N/A
- MRSN N/A
- Industry
- PPSI Electrical Products
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- PPSI Industrials
- MRSN Health Care
- Exchange
- PPSI Nasdaq
- MRSN Nasdaq
- Market Cap
- PPSI 46.6M
- MRSN 47.1M
- IPO Year
- PPSI N/A
- MRSN 2017
- Fundamental
- Price
- PPSI $4.63
- MRSN $9.44
- Analyst Decision
- PPSI Strong Buy
- MRSN Strong Buy
- Analyst Count
- PPSI 1
- MRSN 3
- Target Price
- PPSI $12.00
- MRSN $33.00
- AVG Volume (30 Days)
- PPSI 119.6K
- MRSN 66.4K
- Earning Date
- PPSI 11-13-2025
- MRSN 11-13-2025
- Dividend Yield
- PPSI 32.40%
- MRSN N/A
- EPS Growth
- PPSI N/A
- MRSN N/A
- EPS
- PPSI 2.91
- MRSN N/A
- Revenue
- PPSI $31,279,000.00
- MRSN $34,769,000.00
- Revenue This Year
- PPSI $27.32
- MRSN N/A
- Revenue Next Year
- PPSI $16.14
- MRSN N/A
- P/E Ratio
- PPSI $1.59
- MRSN N/A
- Revenue Growth
- PPSI 105.82
- MRSN 16.14
- 52 Week Low
- PPSI $2.25
- MRSN $5.21
- 52 Week High
- PPSI $6.80
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- PPSI 56.25
- MRSN 52.34
- Support Level
- PPSI $4.36
- MRSN $9.24
- Resistance Level
- PPSI $4.72
- MRSN $9.87
- Average True Range (ATR)
- PPSI 0.26
- MRSN 0.70
- MACD
- PPSI -0.02
- MRSN -0.17
- Stochastic Oscillator
- PPSI 46.58
- MRSN 28.81
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.